Determine the most effective and efficient treatment protocols for treating neck pain with LLLT.
The purpose of this study is to identify what are the most effective low level laser therapy (LLLT) dosimetry parameters when treating pilots and navigators complaining of flight related neck pain.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
80
Utilizing the Pinnacle Series Laser by Aspen Laser Systems, investigators will apply 635-780nm, 10 mW cw, \~ 5-105 J/cm2 at the following time and mW intervals. The beam will be applied at 12 application patterns equidistant and parallel to each other. Each application point will be treated for the timeframes referenced below: * Subgroup 1: 10 minutes at 5 mW * Subgroup 2: 10 minutes at 15 mW * Subgroup 3: 10 minutes at 32 mW * Subgroup 4: 15 minutes at 5 mW * Subgroup 5: 15 minutes at 15 mW * Subgroup 6: 15 minutes at 32 mW
Utilizing the Pinnacle Series Laser by Aspen Laser Systems, we will apply 830nm, 30- 50mW cw, \~ 1-20 J/cm2 at the following time and mW intervals. The beam will be applied at 12 application patterns equidistant and parallel to each other. Each application point will be treated for the timeframes referenced below: * Subgroup 1: 10 minutes at 5 mW * Subgroup 2: 10 minutes at 15 mW * Subgroup 3: 10 minutes at 32 mW * Subgroup 4: 15 minutes at 5 mW * Subgroup 5: 15 minutes at 15 mW * Subgroup 6: 15 minutes at 32 mW
Mike O'Callaghan Military Medical Center
Las Vegas, Nevada, United States
Number of grounding days from flying due to neck pain -- Interval Variable
Number of grounding days from flying due to neck pain -- Interval Variable
Time frame: Record during screening visit
Change in Neck Disability Index (NDI)
The NDI assessing functional capacity, has 10 parts, which evaluate pain intensity, personal care, lifting objects, reading, headache, concentration, work, driving, sleeping, and recreation. NDI scores, ranging from 0-50, may be doubled and also expressed as a percentage of function on a scale of 0-100%; thereby allowing the measure to be treated as an interval variable. It has also been categorized into 5 ordinal measurements, which are shown below with corresponding score and percentage measurements: * NDI Score 0-4 (0-8%) is total capacity (no disability) * NDI Score 5-14 (10-28%) is mild incapacity (mild disability) * NDI Score 15-24 (30-48%) is mild incapacity (moderate disability) * NDI Score 25-34 (50-64%) is serious capacity (severe disability) * NDI Score 35-50 (70-100%) is severe incapacity (complete disability)
Time frame: visit 0 (screening visit), visit 1 (day 1), visit 10 (day 10)
Change in Defense and Veterans Pain Rating Scale (DVPRS)
The Defense and Veterans Pain Rating Scale is an assessment tool that utilizes a numerical rating scale, enhanced by functional word descriptors, color coding, and graphical facial expressions to evaluate a patient's self-reported pain levels. The DVPRS consists of an 11-point numerical rating scale with 0 indicating no pain and 10 indicating severe pain. It has been confirmed for reliability and validity in measuring both acute and chronic pain, and is currently the standard for pain measurement throughout DoD and VA health systems. The DVPRS has demonstrated linear scale qualities allowing parametric methods to be used.
Time frame: visit 0 (screening visit), visit 1 (day 1), visit 10 (day 10)
Change in Interleukin 2 Receptor (CD25) Soluble Biomarker Levels
Phlebotomists will draw 750 uL into 3 separate cryovials on two separate occasions. Interleukin 2 Receptor (CD25) Soluble Standard curve range: 4.25-17400 pg/mL
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Utilizing the Phoenix Thera-Lase by Phoenix Thera-Lase Systems, we will apply 904nm, 40mW (pulsed) @10000Hz, \~ 4-18 J/cm2 at the following time and mW intervals. The beam will be applied at 12 application patterns equidistant and parallel to each other. Each application point will be treated for the timeframes referenced below: * Subgroup 1: 10 minutes at 5 mW * Subgroup 2: 10 minutes at 15 mW * Subgroup 3: 10 minutes at 32 mW * Subgroup 4: 15 minutes at 5 mW * Subgroup 5: 15 minutes at 15 mW * Subgroup 6: 15 minutes at 32 mW
Time frame: day 0 (pre-treatment), day 10 (post-treatment)
Change in Interleukin 12 biomarker Levels
Phlebotomists will draw 750 uL into 3 separate cryovials on two separate occasions. Interleukin 12 Standard curve range: 1.56-6400 pg/mL
Time frame: day 0 (pre-treatment), day 10 (post-treatment)
Change in Interleukin 4 Biomarker Levels
Phlebotomists will draw 750 uL into 3 separate cryovials on two separate occasions. Interleukin 4 Standard curve range: 9.35-38300 pg/mL
Time frame: day 0 (pre-treatment), day 10 (post-treatment)
Change in Interleukin 5 biomarker Levels
Phlebotomists will draw 750 uL into 3 separate cryovials on two separate occasions. Interleukin 5 Standard curve range: 6.52-26700 pg/mL
Time frame: day 0 (pre-treatment), day 10 (post-treatment)
Change in Interleukin 10 Biomarker Levels
Phlebotomists will draw 750 uL into 3 separate cryovials on two separate occasions. Interleukin 10 Standard curve range: 2.49-10200 pg/mL
Time frame: day 0 (pre-treatment), day 10 (post-treatment)
Change in Interleukin 13 Biomarker Levels
Phlebotomists will draw 750 uL into 3 separate cryovials on two separate occasions. Interleukin 13 Standard curve range: 3.27-13400 pg/mL
Time frame: day 0 (pre-treatment), day 10 (post-treatment)
Change in Interleukin 1 beta Biomarker Levels
Phlebotomists will draw 750 uL into 3 separate cryovials on two separate occasions. Interleukin 1 beta Standard curve range: 2.39-9800 pg/mL
Time frame: day 0 (pre-treatment), day 10 (post-treatment)
Change in Interleukin 6 Biomarker Levels
Phlebotomists will draw 750 uL into 3 separate cryovials on two separate occasions. Interleukin 6 Standard curve range: 6.74-27600 pg/mL
Time frame: day 0 (pre-treatment), day 10 (post-treatment)
Change in Interleukin 8 Biomarker Levels
Phlebotomists will draw 750 uL into 3 separate cryovials on two separate occasions. Interleukin 8 Standard curve range: 2.38-9750 pg/mL
Time frame: day 0 (pre-treatment), day 10 (post-treatment)
Change in Tumor Necrosis Factor - alpha Biomarker Levels
Phlebotomists will draw 750 uL into 3 separate cryovials on two separate occasions. Tumor Necrosis Factor - alpha Standard curve range: 6.42-26300 pg/mL
Time frame: day 0 (pre-treatment), day 10 (post-treatment)
Change in Interleukin 2 Biomarker Levels
Phlebotomists will draw 750 uL into 3 separate cryovials on two separate occasions. Interleukin 2 Standard curve range: 4.25-17400 pg/mL
Time frame: day 0 (pre-treatment), day 10 (post-treatment)
Change in Interleukin 17 Biomarker Levels
Phlebotomists will draw 750 uL into 3 separate cryovials on two separate occasions. Interleukin 17 Standard curve range: 2.22-9100 pg/mL
Time frame: day 0 (pre-treatment), day 10 (post-treatment)
Change in cyclooxygenase (COX-2 Biomarker Levels
Phlebotomists will draw 750 uL into 3 separate cryovials on two separate occasions. cyclooxygenase (COX-2) Standard curve range: 7.5 U/ml - 60 U/ml
Time frame: day 0 (pre-treatment), day 10 (post-treatment)
Change in cortisol Biomarker Levels
Phlebotomists will draw 750 uL into 3 separate cryovials on two separate occasions. cortisol * Standard curve range: cortisol will be compared to normal reference range for the time the blood is drawn, which is noted on lab report * 8AM sample using the new assays is 10 to 50 picograms per milliliter (pg/ml); levels are usually less than 20 pg/ml at 4 PM and less than 5-10 pg/ml at midnight.
Time frame: day 0 (pre-treatment), day 10 (post-treatment)
Change in substance P Biomarker Levels
Phlebotomists will draw 750 uL into 3 separate cryovials on two separate occasions. substance P Standard curve range: N/A, values from day 0 time will be compared with day 10 values
Time frame: day 0 (pre-treatment), day 10 (post-treatment)
Change in C-reactive protein Biomarker Levels
Phlebotomists will draw 750 uL into 3 separate cryovials on two separate occasions. C-reactive protein Standard curve range: 3 mg/L-10 mg/L
Time frame: day 0 (pre-treatment), day 10 (post-treatment)
Change in alpha-1 antitrypsin Biomarker Levels
Phlebotomists will draw 750 uL into 3 separate cryovials on two separate occasions. alpha-1 antitrypsin Standard curve range: 100-300 mg/dL
Time frame: day 0 (pre-treatment), day 10 (post-treatment)